FIELD: biology.
SUBSTANCE: invention relates to biology and genetic engineering. Disclosed is an isolated peptide for therapeutic purposes, containing a sequence at least 95% identical to SEQ ID NO: 4 (GG00444), or its fragment or variant, capable of binding with human bowel mucus, as well as fimbriated structure comprising same, food product, pharmaceutical composition, polynucleotide, expression vector, host cell, gene cluster, antibody, method of treatment and method of screening probiotic bacterial strains.
EFFECT: treatment of intestinal diseases.
33 cl, 11 dwg, 2 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATES OF GHRELIN CARRIER | 2003 |
|
RU2325202C2 |
| ANTIGEN MATRIX FOR TREATMENT OF BONE DISEASE | 2002 |
|
RU2322258C2 |
| COMPOSITION FOR IMMUNIZATION (VARIANTS), METHOD FOR ITS PREPARING AND USING FOR TREATMENT OF ALLERGIC EOSINOPHILIC DISEASES | 2002 |
|
RU2319503C2 |
| CONJUGATE OF ANGIOTENSIN PEPTIDE COMPONENT WITH CARRIER, VACCINE COMPOSITION, METHOD OF ANIMAL IMMUNISATION AND METHOD OF TREATMENT OR PREVENTION OF PHYSICAL DISORDER RELATED TO ANGIOTENSIN SYSTEM ACTIVATED BY RENIN | 2002 |
|
RU2350622C2 |
| COMPOSITION AND METHOD FOR IMMUNISATION, METHOD OF PRODUCING UNNATURAL, ORDERED AND REPEATING MASSIVE OF ANTIGENS | 2002 |
|
RU2438701C2 |
| COMPOSITION AND IMMUNIZATION METHOD, METHODS FOR PRODUCING NON-NATURAL, ORDERED AND REPEATED ANTIGEN MASSIVE AND COAT PROTEIN | 2002 |
|
RU2295973C2 |
| COMPOSITION AND METHOD FOR IMMUNIZATION, METHOD FOR PRODUCING OF NON-NATURAL, ORDERED AND REPEATED ANTIGEN MASSIVE | 2002 |
|
RU2294211C2 |
| METHOD FOR DETERMINING ACTIVITY OF SORTASE A | 2024 |
|
RU2840257C1 |
| IpaD-PROTEIN SHIGELLA AND APPLYING IT AS SHIGELLA INFECTIONS VACCINE | 2007 |
|
RU2450826C2 |
| CLOSTRIDIAL TOXIN NetB | 2008 |
|
RU2474587C2 |
